147 related articles for article (PubMed ID: 9330227)
21. The lectin domain of UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-T4 directs its glycopeptide specificities.
Hassan H; Reis CA; Bennett EP; Mirgorodskaya E; Roepstorff P; Hollingsworth MA; Burchell J; Taylor-Papadimitriou J; Clausen H
J Biol Chem; 2000 Dec; 275(49):38197-205. PubMed ID: 10984485
[TBL] [Abstract][Full Text] [Related]
22. Substrate specificities of three members of the human UDP-N-acetyl-alpha-D-galactosamine:Polypeptide N-acetylgalactosaminyltransferase family, GalNAc-T1, -T2, and -T3.
Wandall HH; Hassan H; Mirgorodskaya E; Kristensen AK; Roepstorff P; Bennett EP; Nielsen PA; Hollingsworth MA; Burchell J; Taylor-Papadimitriou J; Clausen H
J Biol Chem; 1997 Sep; 272(38):23503-14. PubMed ID: 9295285
[TBL] [Abstract][Full Text] [Related]
23. The interdomain flexible linker of the polypeptide GalNAc transferases dictates their long-range glycosylation preferences.
de Las Rivas M; Lira-Navarrete E; Daniel EJP; Compañón I; Coelho H; Diniz A; Jiménez-Barbero J; Peregrina JM; Clausen H; Corzana F; Marcelo F; Jiménez-Osés G; Gerken TA; Hurtado-Guerrero R
Nat Commun; 2017 Dec; 8(1):1959. PubMed ID: 29208955
[TBL] [Abstract][Full Text] [Related]
24. Mucin core O-glycosylation is modulated by neighboring residue glycosylation status. Kinetic modeling of the site-specific glycosylation of the apo-porcine submaxillary mucin tandem repeat by UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases T1 and T2.
Gerken TA; Zhang J; Levine J; Elhammer A
J Biol Chem; 2002 Dec; 277(51):49850-62. PubMed ID: 12397077
[TBL] [Abstract][Full Text] [Related]
25. Characterization of a novel human UDP-GalNAc transferase, pp-GalNAc-T10.
Cheng L; Tachibana K; Zhang Y; Guo Jm; Kahori Tachibana K; Kameyama A; Wang H; Hiruma T; Iwasaki H; Togayachi A; Kudo T; Narimatsu H
FEBS Lett; 2002 Nov; 531(2):115-21. PubMed ID: 12417297
[TBL] [Abstract][Full Text] [Related]
26. UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase. Identification and separation of two distinct transferase activities.
Sørensen T; White T; Wandall HH; Kristensen AK; Roepstorff P; Clausen H
J Biol Chem; 1995 Oct; 270(41):24166-73. PubMed ID: 7592620
[TBL] [Abstract][Full Text] [Related]
27. Mucin-type O-glycosylation is controlled by short- and long-range glycopeptide substrate recognition that varies among members of the polypeptide GalNAc transferase family.
Revoredo L; Wang S; Bennett EP; Clausen H; Moremen KW; Jarvis DL; Ten Hagen KG; Tabak LA; Gerken TA
Glycobiology; 2016 Apr; 26(4):360-76. PubMed ID: 26610890
[TBL] [Abstract][Full Text] [Related]
28. Identification of common and unique peptide substrate preferences for the UDP-GalNAc:polypeptide alpha-N-acetylgalactosaminyltransferases T1 and T2 derived from oriented random peptide substrates.
Gerken TA; Raman J; Fritz TA; Jamison O
J Biol Chem; 2006 Oct; 281(43):32403-16. PubMed ID: 16912039
[TBL] [Abstract][Full Text] [Related]
29. Cloning of a human UDP-N-acetyl-alpha-D-Galactosamine:polypeptide N-acetylgalactosaminyltransferase that complements other GalNAc-transferases in complete O-glycosylation of the MUC1 tandem repeat.
Bennett EP; Hassan H; Mandel U; Mirgorodskaya E; Roepstorff P; Burchell J; Taylor-Papadimitriou J; Hollingsworth MA; Merkx G; van Kessel AG; Eiberg H; Steffensen R; Clausen H
J Biol Chem; 1998 Nov; 273(46):30472-81. PubMed ID: 9804815
[TBL] [Abstract][Full Text] [Related]
30. The acceptor specificity of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases.
Elhammer AP; Kézdy FJ; Kurosaka A
Glycoconj J; 1999 Feb; 16(2):171-80. PubMed ID: 10612416
[TBL] [Abstract][Full Text] [Related]
31. Enzymatic glycosylation of contulakin-G, a glycopeptide isolated from Conus venom, with a mammalian ppGalNAc-transferase.
Craig AG; Park M; Fischer WH; Kang J; Compain P; Piller F
Toxicon; 2001 Jun; 39(6):809-15. PubMed ID: 11137540
[TBL] [Abstract][Full Text] [Related]
32. Elucidation of the sugar recognition ability of the lectin domain of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 3 by using unnatural glycopeptide substrates.
Yoshimura Y; Nudelman AS; Levery SB; Wandall HH; Bennett EP; Hindsgaul O; Clausen H; Nishimura S
Glycobiology; 2012 Mar; 22(3):429-38. PubMed ID: 22042768
[TBL] [Abstract][Full Text] [Related]
33. Unexpected tolerance of glycosylation by UDP-GalNAc:polypeptide alpha-N-acetylgalactosaminyltransferase revealed by electron capture dissociation mass spectrometry: carbohydrate as potential protective groups.
Yoshimura Y; Matsushita T; Fujitani N; Takegawa Y; Fujihira H; Naruchi K; Gao XD; Manri N; Sakamoto T; Kato K; Hinou H; Nishimura S
Biochemistry; 2010 Jul; 49(28):5929-41. PubMed ID: 20540529
[TBL] [Abstract][Full Text] [Related]
34. Conservation of peptide acceptor preferences between Drosophila and mammalian polypeptide-GalNAc transferase ortholog pairs.
Gerken TA; Ten Hagen KG; Jamison O
Glycobiology; 2008 Nov; 18(11):861-70. PubMed ID: 18669915
[TBL] [Abstract][Full Text] [Related]
35. An alpha-N-acetylgalactosaminylation at the threonine residue of a defined peptide sequence creates the oncofetal peptide epitope in human fibronectin.
Matsuura H; Greene T; Hakomori S
J Biol Chem; 1989 Jun; 264(18):10472-6. PubMed ID: 2471705
[TBL] [Abstract][Full Text] [Related]
36. A novel human UDP-N-acetyl-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase, GalNAc-T7, with specificity for partial GalNAc-glycosylated acceptor substrates.
Bennett EP; Hassan H; Hollingsworth MA; Clausen H
FEBS Lett; 1999 Oct; 460(2):226-30. PubMed ID: 10544240
[TBL] [Abstract][Full Text] [Related]
37. Studies on the order and site specificity of GalNAc transfer to MUC1 tandem repeats by UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferase from milk or mammary carcinoma cells.
Stadie TR; Chai W; Lawson AM; Byfield PG; Hanisch FG
Eur J Biochem; 1995 Apr; 229(1):140-7. PubMed ID: 7744025
[TBL] [Abstract][Full Text] [Related]
38. Engineering of N. benthamiana L. plants for production of N-acetylgalactosamine-glycosylated proteins--towards development of a plant-based platform for production of protein therapeutics with mucin type O-glycosylation.
Daskalova SM; Radder JE; Cichacz ZA; Olsen SH; Tsaprailis G; Mason H; Lopez LC
BMC Biotechnol; 2010 Aug; 10():62. PubMed ID: 20735851
[TBL] [Abstract][Full Text] [Related]
39. Site-specific O-glycosylation of N-terminal serine residues by polypeptide GalNAc-transferase 2 modulates human δ-opioid receptor turnover at the plasma membrane.
Lackman JJ; Goth CK; Halim A; Vakhrushev SY; Clausen H; Petäjä-Repo UE
Cell Signal; 2018 Jan; 42():184-193. PubMed ID: 29097258
[TBL] [Abstract][Full Text] [Related]
40. Application of bioinformatics in search for cleavable peptides of SARS-CoV M(pro) and chemical modification of octapeptides.
Du Q; Wang S; Jiang Z; Gao W; Li Y; Wei D; Chou KC
Med Chem; 2005 May; 1(3):209-13. PubMed ID: 16787316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
